These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 6378975)

  • 21. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.
    Carlson LA; Holmquist L; Nilsson-Ehle P
    Acta Med Scand; 1986; 219(5):435-47. PubMed ID: 3739751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins.
    Hara T; Miller JP; Gotto AM; Patsch JR
    Artery; 1981; 9(5):328-41. PubMed ID: 7316782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients.
    Dachet C; Cavallero E; Martin C; Girardot G; Jacotot B
    Atherosclerosis; 1995 Feb; 113(1):1-9. PubMed ID: 7755644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia.
    Bai H; Liu BW; Deng ZY; Shen T; Fang DZ; Zhao YH; Liu Y
    Free Radic Biol Med; 2006 May; 40(10):1796-803. PubMed ID: 16678017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of lipoprotein profiles in newborns by density gradient ultracentrifugation.
    Rosseneu M; Van Biervliet JP; Bury J; Vinaimont N
    Pediatr Res; 1983 Oct; 17(10):788-94. PubMed ID: 6634243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
    Kleinmann Y; Oschry Y; Berger GM; Eisenberg S
    Atherosclerosis; 1988 Jun; 71(2-3):197-204. PubMed ID: 3401291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of composition and of in vitro lipolysis products of human small very low density lipoproteins in hypertriglyceridemia.
    Tornvall P; Hamsten A; Carlson LA
    Atherosclerosis; 1990 May; 82(1-2):125-35. PubMed ID: 2360914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma triglyceride determines structure-composition in low and high density lipoproteins.
    Deckelbaum RJ; Granot E; Oschry Y; Rose L; Eisenberg S
    Arteriosclerosis; 1984; 4(3):225-31. PubMed ID: 6712536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N; Cloarec M; Jacotot B
    Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases.
    Deckelbaum RJ; Eisenberg S; Oschry Y; Granot E; Sharon I; Bengtsson-Olivecrona G
    J Biol Chem; 1986 Apr; 261(11):5201-8. PubMed ID: 3957920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG; Lavy A; Aviram M; Zinder O
    Atherosclerosis; 1980 Aug; 36(4):461-9. PubMed ID: 7417365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.